Cargando…
A Pilot Study on the Efficacy and Safety of 0.01% Atropine in German Schoolchildren with Progressive Myopia
INTRODUCTION: Although the interest is growing in topical low-dose atropine to control myopia in schoolchildren worldwide, its use in children of European ancestry remains controversial and solid evidence is sparse. The Oxford Centre for Evidence Based Medicine (OCEBM) classifies the evidence for th...
Autores principales: | Joachimsen, Lutz, Böhringer, Daniel, Gross, Nikolai J., Reich, Michael, Stifter, Julia, Reinhard, Thomas, Lagrèze, Wolf A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692800/ https://www.ncbi.nlm.nih.gov/pubmed/31190219 http://dx.doi.org/10.1007/s40123-019-0194-6 |
Ejemplares similares
-
Side effects of topical atropine 0.05% compared to 0.01% for myopia control in German school children: a pilot study
por: Joachimsen, Lutz, et al.
Publicado: (2021) -
Effect of atropine 0.01% on progression of myopia
por: Sen, Snigdha, et al.
Publicado: (2022) -
Effects of atropine 0.01% on refractive errors in children with myopia
por: Zhu, Xingxue, et al.
Publicado: (2023) -
Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children
por: Zhao, Qi, et al.
Publicado: (2020) -
Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control
por: Zhang, Xiaoyu, et al.
Publicado: (2020)